BLOOD TRANSFUSION DETAILS


Contents:

Why you may need blood transfusion

Who needs blood transfusion

Autologous (own blood) transfusion , risks and benefits

Allogenic (alien blood) transfusion, risks and benefits


1

Why will the patient need a blood transfusion

(A little common sense theory)

When considering the blood loss during surgery and its replacement, you must distinguish between two different effects of blood loss. The blood loss affects

1) the oxygen carrying capacity of blood and it also affects

2) the capacity of blood to perfuse (circulate through) important organs in the body.

1) Oxygen carrying capacity of the blood

If the blood loss caused a severe drop in the level of of hemoglobin ( usually under 100 g/Lt) then the transport of sufficient quantity of oxygen from lung to important organs (heart, kidneys) may be jeopardised. This is more likely to happen in patients who preoperatively have had low concentrations of hemoglobine.

In these patients it is important to increase the level of hemoglobin in their blood to secure the transport of sufficient quantity of oxygen to the important organs. The anaesthesiologist / surgeon must replace the hemoglobin loss by blood transfusion.

The patient in this case will receive one or more units of blood transfusion; every such unit corresponds to 225 to 300 ml of concentrated red blood cells (erythrocytes) suspended in blood plasma, anticoagulants (substances that prevent the blood to congeal) and other substance to increase the shell life of stored blood to 42 days.


 

2) The perfusion capacity of the blood

When there has been severe loss of blood volume during surgery, the remaining blood may still have sufficient concentration of hemoglobin   to carry oxygen to the important organs, but the volume of the remaining blood may be just too small to perfuse these organs effectively. This often happens in patients who have had preoperatively high concentration of hemoglobin ( > 150 g/Lt).

In this case it suffices if the the anaesthesiologist / surgeon expands the volume of blood with blood expanding liquids, the simplest such liquid is physiological solution (0,9% salt solution in water). The expanded blood volume will guarantee sufficient transport of oxygen. Blood transfusion should not be used to expand the quantity of circulating blood only. (Lemos 1996)


2

Indications for transfusion (who needs transfusion)

At present there are no generally accepted, all-encompassing rules to decide which patient will need blood transfusion during and after the total joint surgery. Decision to order blood transfusion involves multiple factors. According to the traditional rule, originating in 1942 (!), transfusion is recommended when the level of hemoglobin is less than 110 g/Lt.

This rule has been questioned, because the hemoglobin level cannot be a static number. Much depends on the preoperative level and the suddenness of the drop in the hemoglobin kevel. The decision rules regarding transfusion must also include an assessment of the patient’s symptoms, not only his /her laboratory values.

 

Symptoms of low hemoglobin level are shortness of breath, quick pulse not responding to infusion of blood expanders, angina (heart ache), dizziness, postural hypotension (drop of blood pressure when raising up), excessive fatigue.


3

Autologous transfusion, benefits and risks

In the 1960 and 1970's many units of allogenic blood and blood plasma were contaminated with HIV and hepatitis viruses. Many patients who needed blood transfusions often (haemophiliacs) or children who needed blood transfusion during spinal operations were the first innocent victims of this epidemic.

Preoperative donation of autologous blood as a means to eliminate this risk was introduced first for adolescent patients operated on for spinal deformity.

Fears of transmission of HIV virus and viral hepatitis triggered the use of autologous transfusions in patients operated on with total joints too.

Despite markedly decreased risks of viral contamination of the current allogenic blood supply, the patients and the surgeons still strongly prefer the use of autologous blood in total joint surgery.

There are as yet no conclusive studies determining which total joint patients are likely to benefit from pre-donation of autologous blood.

 

The lack of such studies has two consequences:

1) too many patients who will not need transfusion during / after surgery still donate their blood preoperatively. The blood of these patients is discarded, increasing the costs of the autologous blood donations.

2) Preoperative blood donation usually lowers hemoglobin levels with 9 - 12 g/Lt, causing even mild anaemia in some of them. Lower hemoglobin level will increase the risk that these patient will need transfusion (albeit of their own blood). . Because the autologous blood transfusion has its risks too, the donor patients are exposed unnecessarily to these risks. Again a "moment 22" situation.


 

Benefits of autologous blood donation

1 ) The donor patients (patients who donated their blood before the surgery) have three to five times lower risk to get allogenic (alien) blood transfusion then the nondonor patients (the patients who did not donate their blood before the surgery)

 

PER CENT OF PATIENTS  WHO RECEIVED ALLOGENIC  BLOOD
Type of operation Nondonors

 

Donors
Primary total hip / knee 15 % 3 %
Bilateral or revision total hip / knee 49 % 19 %

 

(Hatzidakis 2000)

 

2 ) The donor patients who receive only their own (autologous) blood will escape all the risks associated with the transfusion of allogenic (alien) blood. ( See later)


 

Disadvantages / risks of autologous blood donation

Collection  of autologous blood from the patient is not problem-free.

Most important risk pertains to the fact, that donating your blood lowers your hemoglobine level by 9 to 12 g/Lt. Lower hemoglobin level will increase the risk that you will need transfusion of your blood ( a " moment 22" situation).

Multiple phlebotomies (sticks in the vein) are painful, time-consuming, and the treatment with iron afterwards causes bowel problems.

Sudden drop of blood pressure, severe muscle convulsions, heartache (angina), inflammation and severe damage of the veins occur in 2 to 5 per cent of patients during blood donation procedure. In 0,006 % of cases, these complications necessitated a hospital stay. Extremely rare risk, but it is still present.


 

Disadvantages / risks of autologous blood transfusion

It may surprise you, that transfusion of your own blood entails also risk of complications

Most often observed reaction is a febrile reaction to the autologous transfusion, which occurs in about 2 to 4 % of all such transfusions, but on rare occasions ( 0,01 % of all cases) there may occur also more severe reactions.

Who should be observant:

More prone to these reactions are women weighting <55 kg (110 pounds), people with previous reaction to transfusion, and people with coronary artery disease.

Human (clerk) error also applies to autologous transfusion - you may get an incorrect blood unit destined for another patient. This happens in 0, 003% to 0, 0006 % of all autologous transfusions. Again, this risk is very small but it exists.


 

Why is the not transfused autologous blood discarded

When you donate your own blood, the blood bank uses fewer strict criteria to accept you as donor of autologous blood. Among them, your hemoglobin level should be > 110 g/Lt only, whereas for allogenic donors the hemoglobin this level is >125 g/Lt. Testing for transmissible diseases may be less strict or entirely absent for donors of autologous blood.

So it is safe to discard the non-used autologous blood. It is again a " moment 22" situation . The less strict criteria for autologous blood donation are used to make it cheaper. But because so many unit of autologous blood are discarded, the autologous blood is actually more expensive than the allogenic blood.

Incidentally, autologous donors who fulfill the more strict criteria valid for allogenic donors have only half so many complications after transfusion of their own blood compared with people who donated their blood according to the relaxed criteria.


4

Disadvantages and complications of allogenic transfusion.

Transmission of diseases

It is the most feared risk associated with the transfusion of allogenic blood.

Although the HIV virus is the most feared, the risk of contracting hepatitis (liver inflammation) from allogenic transfusion is far greater than that of contracting HIV. In one report the risk of death from hepatitis C was 98 times greater than the risk to die by HIV infection contracted by allognic blood transfusion

RISKS  ASSOCIATED  WITH  ALLOGENIC  TRANSFUSION
Complication Prevalence per cent
Any transfusion reaction 5 %
Fever or urticaria 0,03 %
Non lethal hemolytic reaction 0,004%
Lethal hemolytic reaction < 0,0001%
Transmission of HIV 0,0002 %
Transmission of hepatitis C virus 0,002 %
Postoperative infection, increase of risk 20 % (?)

(Lemos 2000)

Febrile response :

Fever is usually associated with chills, general discomfort, or even severe pain. It occurs more often as reaction to white blood cells transfused together with red blood cells. In very rare cases it may be caused by bacterial contamination of the blood.


Allergic or immune reaction:

This reaction consists of fever, chills, and urticaria (nettle). The first allogenic transfusion may go undetected and make the patient sensitive for further such transfusions that then produce severe allergic reaction.


Hemolysis

Hemoglobin, the dye contained in the red blood cells, is a very dangerous substance when it escapes from the red blood cells and circulates freely in the blood. This state is called hemolysis.

The free molecules of hemoglobin circulating in the blood clog the kidneys. This is a very serious complication caused by transfusion of wrong blood group blood.

The symptoms are fever, chills, chest pain, sudden blood pressure fall, occurrence of hemoglobin in the urine ( if the patient produces any urine at all)

________________

References

Hatzidakis AM et al. J Bone Joint Surg-Am, 2000; 82-A: 89 - 100

Lemos MJ et Healy WL . J Bone Joint Surg-Am, 1996; 78-A: 1260 - 1270